Six-month Angiographic and 2-year clinical outcomes
| Variable, n (%) | SES Group (n=102 pts, 247 lesions) | PES Group (n=138 pts, 414 lesions) | ZES Group (n=65 pts, 138 lesions) | P value |
| Stent diameter, mm | 2.95±0.36 | 2.86±0.38 | 3.03±0.44 | <0.001 |
| Stent length, mm | 26.87±6.49 | 25.61±7.08 | 24.10±5.87 | 0.008 |
| Binary restenosis | 12 (7.5) | 40 (15.9) | 16 (19.8) | 0.013 |
| Restenosis percent, % | 19.45±17.86 | 28.51±21.93 | 32.44±25.71 | <0.001 |
| Late loss, mm | 0.45±0.49 | 0.85±1.72 | 0.73±0.69 | 0.008 |
| Cardiac death | 2 (2.0) | 1 (0.7) | 1 (1.5) | 0.696 |
| Q-wave MI | 0 (0) | 0 (0) | 0 (0) | 1.000 |
| Non-Q-wave MI | 0 (0) | 0 (0) | 0 (0) | 1.000 |
| TLR | 6 (5.9) | 16 (11.6) | 9 (13.8) | 0.190 |
| TVR | 8 (7.8) | 22 (15.9) | 12 (18.5) | 0.092 |
| TVR-MACE | 13 (12.7) | 25 (18.1) | 15 (23.1) | 0.218 |
| Stent thrombosis | 0 (0) | 0 (0) | 3 (4.6) | 0.004 |